Pharmaceuticals

Single-Cell Omics Market Trends, Drivers, and Regional Analysis 2025–2029

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the single-cell omics market from 2025–2034 with trusted insights from The Business Research Company

How Is The Single-Cell Omics Market Size Expected To Expand Over 2029-2034?

The market for isotretinoin drugs has experienced consistent expansion over recent years. It is projected to grow from $1.29 billion in 2024 to $1.35 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.7%. This historic growth can be attributed to factors such as the widespread occurrence of severe acne, the demonstrated effectiveness of isotretinoin, various marketing and public awareness initiatives, successful regulatory clearances, and an increase in dermatology consultations.

The isotretinoin drugs market is projected to experience consistent expansion over the upcoming years. This market is forecast to reach $1.63 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth during the forecast period include rising awareness and evolving skincare trends, the expansion into developing markets, a higher prevalence of acne, an aging global demographic, and an increased emphasis on mental health and personal well-being. Key trends anticipated within this period encompass ongoing research and development efforts, significant technological advancements, innovations in generic drug options, enhancements in drug formulations, and progress within the field of dermatology.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16095&type=smp

Which Market Factors Are Fueling The Single-Cell Omics Industry Growth?

An increase in skin cancer diagnoses is projected to fuel the expansion of the isotretinoin drugs market moving ahead. This condition, skin cancer, involves the uncontrolled multiplication of atypical skin cells, primarily resulting from extended exposure to ultraviolet (UV) radiation from natural sunlight or tanning equipment. The surge in skin cancer incidents is chiefly attributable to heightened exposure to ultraviolet (UV) radiation from the sun and tanning beds, compounded by factors such as the depletion of the ozone layer and shifts in lifestyle encouraging more outdoor pursuits without proper sun safety. Isotretinoin drugs are utilized in the prevention and treatment of specific forms of skin cancer because of their effectiveness in curbing the spread of abnormal skin cells. For example, the American Cancer Society, a US-based non-profit organization committed to eradicating cancer, indicated that by January 2024, there would be 108,270 documented instances of skin cancer, representing a 3.2% rise from the 104,930 cases recorded in 2023. Consequently, the increasing prevalence of skin cancer will stimulate the expansion of the isotretinoin drugs market.

Which Categories Are Covered In The Single-Cell Omics Market Segmentation Analysis?

The isotretinoin drugs market covered in this report is segmented –

1) By Form: Capsules, Injection

2) By Indication Type: Severe Acne, Neuroblastoma, Cutaneous T-Cell Lymphoma, Harlequin Ichthyosis, Xeroderma Pigmentosum, Fibrodysplasia Ossificans Progressiva, Squamous Cell Skin Cancers, Other Indication Types

3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Capsules: Soft Gel Capsules, Hard Gel Capsules, Liquid-Filled Capsules

2) By Injection: Intravenous Injection, Intramuscular Injection

Which Market Trends Are Expected To Define The Future Of The Single-Cell Omics Market?

Companies operating within the isotretinoin drugs market are focusing on advancements in formulations, such as isotretinoin capsules, to enhance treatment options and increase accessibility for patients. Isotretinoin capsules are prescribed for severe acne cases like nodular or cystic acne, with strict usage guidelines due to significant side effects, especially the high risk of birth defects. For instance, in July 2023, Upsher-Smith Laboratories, LLC, a US-based pharmaceutical company, launched the first Isotretinoin Capsules USP. These are available in 10 mg, 20 mg, 30 mg, and 40 mg dosages. These capsules are therapeutically equivalent (TE code AB1) to the brand Accutane. This medication is prescribed for the treatment of severe acne, offering a proven solution for difficult cases.

Which Organizations Are At The Forefront Of The Single-Cell Omics Market?

Major companies operating in the isotretinoin drugs market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Hetero Drugs Ltd., Sun Pharmaceuticals Industries Limited, Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc, Zydus Lifesciences Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd, Almirall LLC, Alembic Pharmaceuticals Ltd, Ajanta Pharma Ltd, Strides Pharma Science Limited, Wockhardt Ltd., Douglas Pharmaceuticals Limited, Chongqing Huapont Pharm Co. Ltd., Cipher Pharmaceuticals Inc., Vidhyasha Pharmaceuticals

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/isotretinoin-drugs-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Single-Cell Omics Market?

North America was the largest region in the isotretinoin drugs market in 2024. The regions covered in the isotretinoin drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=16095&type=smp

Browse Through More Reports Similar to the Global Single-Cell Omics Market 2025, By The Business Research Company

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Skin Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

Pancreatic Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795